Echocardiographic evaluation of left ventricular systolic function in patients with new onset non-ST elevation myocardial infarction
European Journal of Clinical Pharmacy · 26.06.2025 · 7 (1) · 8520-8525
DOI: 10.61336/ejcp/25-08-549 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 26.06.2025. Verfasst von Bilal Mustafa.
Abstract (Originalsprache)
Objectives
To evaluate the left ventricular systolic function in patients presenting with new onset non–ST elevation myocardial infarction using transthoracic echocardiography.Study Design: Descriptive cross-sectional study.Place and duration of study: This study was conducted at the department of Cardiology, Shifa International Hospital Islamabad, Pakistan from Feb-2023 to Jul-2023. Methodology: A total of 70 patients aged ≥ 18 years and admitted to the cardiology unit with a first episode of non–ST elevation myocardial infarction were enrolled. Diagnosis was based on clinical features, absence of persistent ST-segment elevation (on electrocardiography), and elevated cardiac biomarkers. Transthoracic echocardiography was performed and left ventricular systolic function was assessed by calculating left ventricular ejection fraction (modified Simpson’s biplane method) and categorized as normal, mildly reduced, moderately reduced, or severely reduced. Regional wall motion abnormalities were also evaluated using the standard 17-segment model. Descriptive statistics were employed to share the study findings.
Results
The mean age of study patients was 58.93 ± 6.73 years, with a male predominance (67.14%) in overall study population. Mean left ventricular ejection fraction was recorded as 47.24 ± 9.7%. The results showed reduced systolic function in 64.29% of patients, with mild, moderate, and severe dysfunction present in 27.14%, 22.86%, and 14.29%, respectively. Regional wall motion abnormalities were present in 74.29% of patients, where most commonly reported was hypokinesia (45.71%).
Conclusions
Impaired left ventricular systolic function and regional wall motion abnormalities are present in a notable proportion of patients reported with new onset non–ST elevation myocardial infarction
Zitieren
APA
Mustafa, B. (2025). Echocardiographic evaluation of left ventricular systolic function in patients with new onset non-ST elevation myocardial infarction. European Journal of Clinical Pharmacy, 7(1), 8520-8525. https://doi.org/10.61336/ejcp/25-08-549
Vancouver
Mustafa B. Echocardiographic evaluation of left ventricular systolic function in patients with new onset non-ST elevation myocardial infarction. European Journal of Clinical Pharmacy. 2025;7(1):8520-8525. doi:10.61336/ejcp/25-08-549
BibTeX
@article{Mustafa2025,
author = {Mustafa, Bilal},
title = {Echocardiographic evaluation of left ventricular systolic function in patients with new onset non-ST elevation myocardial infarction},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {8520--8525},
doi = {10.61336/ejcp/25-08-549}
}
EUVIMED